Kelly Rachal was 26 when she learned she had ovarian cancer. After a routine ultrasound found her ovaries covered in masses, ...

Without an easy way to screen and with nondescript symptoms, ovarian cancer is often caught in late stages, requiring massive ...

A seven-time Olympic medalist was diagnosed with ovarian cancer after missing the same three warning signs common in early ...

Single-fraction SBRT did not significantly improve bone pain compared to conventional RT. Complete response rates were 37% with SBRT versus 25% with 3D conformal RT at 1 month and remained ...

Pain in your lower right back can be due to many things from a sprain or infection to something more serious like ...

Northwell Health is opening a facility in New Hyde Park that will treat women diagnosed with breast and gynecologic cancers, an official said. The $14 million Center for Women’s Cancer will open Oct.

ATLANTA, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Dogwood Therapeutics, Inc. (DWTX) (“Dogwood” or the “Company”), a clinical-stage biotechnology company developing new medicines to treat pain and neuropathy ...

The potential benefits of GLP-1 medications continue to expand. New research has found that the weight loss and diabetes drugs — officially known as glucagon-like peptide 1 receptor agonists — are ...

-A first-in-class LRP1 agonist, SP16 phase 1b Chemotherapy Induced Neuropathy (CIPN) Study fully funded by the National Cancer Institute, with projected patient enrollment beginning in the first half ...

Sept 29 (Reuters) - AbbVie (ABBV.N), opens new tab said on Monday it would launch its ovarian cancer drug Elahere in the UK at a list price matching that in the U.S. President Donald Trump has been ...